Hospital Pharmacology (Jan 2023)

The association between quality of life and the level of vitamin D in benign prostate hyperplasia

  • Kovačević Rada R.,
  • Peličić Damir N.,
  • Vojinović Tanja B.

DOI
https://doi.org/10.5937/hpimj2302292K
Journal volume & issue
Vol. 10, no. 2
pp. 1292 – 1300

Abstract

Read online

Introduction: Epidemiological studies have suggested an association between vitamin D deficiency and benign prostatic hyperplasia (BPH). The prevalence of vitamin D deficiency in the male population with urological symptoms suggests a relationship between BPH and vitamin D. Methods: This paper will present information from relevant professional/scientific sources regarding the correlation of vitamin D levels with symptom intensity and quality of life of patients with BPH, as well as patient education and health care. Topic: The incidence of BPH is increasing with ageto such extent that it is unusual to find a histologically normal prostate in a man over 70 years of age, thus rising a question whether it should be considered an abnormality at all. From the beginning, the disease was classified as "the agony of the aged man" because benign gland enlargement carries a significant risk of morbidity due to urinary flow obstruction. Due to the long course of benign prostate hyperplasia, which significantly affects the quality of life and quality of sleep, the mental pressure in patients increases, resulting from both physical and mental pain. Therefore, the priority is to focus on medical measures which would improve the quality of life of elderly patients with BPH. Conclusion: After reviewing the literature, we came to the conclusion that the level of vitamin D is responsible for the quality of life of patients with benign prostatic hyperplasia. Health care integration emphasizes the integration of existing resources within the overall health policy planning, and professionally trained medical staff provides medical treatment, rehabilitation, home care, psychological counseling and hospital care for elderly patients with chronic diseases and semi-disabled, disabled and oncological patients.

Keywords